Cramer's Morning Take: Abbott Labs 4/17/24
Jim and Jeff discuss why this healthcare holding is being mismarked by the market. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake